RENAL Flashcards

(36 cards)

1
Q

AKI criteria - any fo the following ?

A
  1. Rise serum creatinine of 26 micromol/litre or greater within 48 hours
  2. 50% or greater rise in serum creatinine known or presumed to have occurred within the past 7 days
  3. Urine output to less than 0.5 ml/kg/hour for more than 6 hours in adults and more than
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Management of hyperkalaemia (>6.5mmol or ECG changes)?

A

-IV calcium gluconate to stabilise myocardium

-Insulin/dextrose infusion

-Nebulised salbutamol may be given to lower serum potassium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the principles of management in hyperkalemia?

A
  1. Stabilisation of cardiac membrane (IV calcium gluconate)
  2. Short term shift of potassium from ECFR to ICF
    -Combined insulin/dextrose infusion
    -Nebulised salbutamol
  3. Rmeoval of potassium from the body
    -Calcium resonium (orally or enema is more effective )
    -Loop diretics
    -Dialysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

When is dialysis considered in hyperkalemia?

A

-Patients with AKI and persistent hyperkalemia

-Heamofiltration/ heamodialysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What management in hyperkalemia lowers the total body potassium?

A

-Calcium resonium
-Loop diuretics
-Dialysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Define contrast media nephrotoxicity

A

-25% increase in creatinine occuring within 3 days of contrast media
-Occurs 2-5 days after administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the risk factors of contrast induced nephrotoxicity?

A

-Renal impairemtn (particulary diabetic)
-Age >70
-Dehydration
-Cardiac failure
-Nephrotoxic drug iuse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Procedures that cause contrast induced nephtopathy?

A

-CT with contrast
-Coronary angiogrpahy/ PCI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What can be given to reduce a patient risk of developinbg contrast induced nephropathy?

A

IV 0.9% sodium chrolide 1ml/kg/hour for 12 hours pre and post procedure (causes volume expansion)

-Also evidence for isotonic sodium bicarbonate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Investigation with AKI?

A
  1. Urinalysis in all patients
  2. RENAL ULTRASOUND if no identifiable cause for AKI or risk of urinary tract obstruction - wihtin 24 HOURS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Chronic kidney disease anaemia is mainly due to what?

A

-Reduced erythropoietin levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What kind of anaemia is usually caused but CKD?

A

normochromic normocytic anaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

When does anaemia become most apparent in patients with CKD?

A
  • GFR <36 ml/min
    -If GFR >60 other causes of anemia should be considered
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What other factors contribute to anaemia in CKD?

A

-Reduced iron absorption
-Reduced erythropoiesis die to toxic effects of uremia on bone marrow
-Anorexia/nausea due to uremia
-Reduced red cell survival (haemodialysis)
-Blood loss due to capillary fragility
-Stress ulceration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Why is there reduced absorption of iron in CKD?

A

1.-Hepcidin levels are increased due to inflammation and reduced renal function
-this leads to a decrease in iron absorption from gut and impaired release of iron from macrophages and hepatocytes
-Iron for erythropoiesis is reduced

  1. In metabolic acidosis iron cannot be converted into its absorbable form in the duodenum so there is reduced iron abosprtion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is target haemoglobin in patients with anaemia in CKD?

17
Q

What is the management of anaemia in CKD?

A

-Determination and optimisation of iron status should be carried out prior to administration of erythropoiesis-stimulating agents (ESA)

18
Q

What is the management of pateitns who are not on ESA or haemodylasis with anameia in CKD?

A

-Oral iron
-If target Hb is not reached within 3 months swtich to IV iron

19
Q

What ESA offered to patients with anaemia in CKD ?

A

-Erythropoietin and darbepoetin

-Should be used in patients who “will benefit in terms of QOL and physical function”

20
Q

What iron treatment should be given to patients on ESA or haemodialysis with anaemia in CKD?

21
Q

What are two types of ADPKD?

A

ADPKD type 1
-85%
-Chromosome 16
-present with renal failure earlier

ADPKD type 2
-15%
-Chromosome 4

22
Q

What is the most common inherited cause of kidney disease?

23
Q

What investiagtion for relatives wiht ADPKD?

24
Q

What is diagnostic criteria of ADPKD in patients with family history?

A

-2 cysts (unilateral or bilateral) if <30
-2 cysts in both kidneys if 30-59
-Four cysts in both kidneys if >60

25
What is the drug that is used in the treatment of ADPKD?
TOLVAPTAN (vasopressin receptor 2 antagonist)
26
When does NICE recommend tolvaptan for treating ADPKD?
-They have CKD stage 2 or 3 at start treatment -Evidence of rapidly progressing disease -Company provides with discount agreed in patient access scheme
27
In patients who are at high risk for contrast induced nephropathy what drug should be withheld?
METFORMIN - should be withheld for a maximum of 48 hours and until renal function has been shown to be normal -This is due to risk of lactic acid acidosis
28
What extra-renal manifestations of ADPKD ?
Most to least common: 1. Liver cysts 2. Cerebral berry aneurysms (can rupture leading to a subarachnoid haemorrhage) 3. Cysts in other organs (pancreas and spleen)
28
Management of severe hypokalaemia (<2.5mmol/l) ?
1.High care area with cardiac monitoring 2.Dilute potassium to low concentration with saline (phlebitic) - if no contraindications to fluid therapy 3. Infusion rate should not exceed 20 mmol/hr (3xL bag 0.9% saline with 40mmol KCL per bag over 24 hours)
29
What is membranous glomerulonephritis?
-Most common type of glomerulonephritis -Presents nephrotic syndrome or proteinuria
30
Renal biopsy membranous glomerulonephritis?
-Basement membrane thickening on light microscopy -Subepithelial spikes on silver stain -'Spiked dome appearance' -+ immunohistochemistry for PLA2
31
Management for membranous glomerulonephritis?
-All patients ACE inhibitor or angiotensin II blocker (reduce proteinuria and improve prognosis ) -Immunosuppression (sometimes with corticosteroid) -Consider anticoagulation for high risk patients
32
Prognosis for membranous glomerulonephritis?
1/3 - spontaneous remission 1/3 - remain proteinuric 1/3 - develop ESRF
33
Biopsy results in focal segmental glomerulosclerosis?
-Focal and segmental sclerosis and hyalinosis on light microscopy -Effacement of foot processes on electron microscopy
34
What does focal segmental glomerulosclerosis cause in patients?
Nephrotic syndrome
35
Management of focal segmental golerulosclerosis?
-Steriods +/- immunosuppressants NOTE: has a high recurrence rate in renal transplants -untreated has <10% of spontaneous remission